NDM-1 and the role of travel in its dissemination

Current Infectious Disease Reports

Volumn 14, Issue 3, 2012, Pages 213-226

  Wilson, Mary Elizabeth ^a,b   Chen, Lin H ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b 330 Mount Auburn Hospital ^*  (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

Author keywords

Antibiotic resistance; Antimicrobial resistance; Beta lactamases; BlaNDM 1; Carbapenemase; Carbapenems; CTX; ESBL (extended spectrum beta lactamases); Gram negatives; Lateral genetic transfer; Medical tourism; Metallo beta lactamases; Mobile genetic elements; Multidrug resistance; NDM 1; New Delhi betalactamase; Resistome

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEMASE; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CAUSAL ATTRIBUTION; DRUG USE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; GENETIC EPIDEMIOLOGY; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HETEROZYGOTE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; NEW DELHI METALLO BETA LACTAMASE 1 GENE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; SHIGELLA BOYDII; TRAVEL; VIBRIO CHOLERAE; WATER CONTAMINATION;

EID: 84865649027     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0252-x     Document Type: Article

References (100)

1. Yong D, Toleman MA, Giske CG, et al.: Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046-54. Paper describes the first patient documented to be infected with NDM-1; characterizes the new metallo-beta-lactamase.
2. Kumarasamy KK, Toleman MA, Walsh TR, et al.: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602. Authors identified NDM-1-positive isolates from India, Pakistan, and the UK. Many of the source patients in had traveled to India or Pakistan. Isolates were multidrug-resistant; resistance on plasmids transferred readily to other Enterobacteriaceae.
3. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis. 2011;17 (10):1791-8. Authors review different classes of beta-lactamases. They summarize the global spread of global spread of NDM-1 producing bacteria.
4. Chen L, Wilson ME. The role of the traveler in emerging infections and magnitude of travel. Med Clin N Amer. 2008;92:1409-32.
5. ReedCM.Medical tourism. Med Clin N America. 2008;92:1433-46.
6. Wilson ME. The traveler and emerging infectious diseases: Sentinel, courier, transmitter. J Appl Microbiol. 2003;94:1S-11S.
7. Walsh TR, Toleman MA, Sarma JB, et al. New Delhi metallo-β-lactamase 1 -Authors reply. Letter Lancet Infect Dis. 2010;10:752-4.
8. Birgy A, Doit C, Mariani-Kurkdjian P, et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol. 2011;49(8):3085-7.
9. Bogaerts P, Bouchahrouf W, Rezende R, et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother. 2011;55(6):3036-8.
10. Brink AJ, Coetzee J, Clay CG, et al.: Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol. 2011; E-pub ahead of print. 11.9.
11. Castanheira M, Deshpande LM, Mathai D, et al.: Early dissemination of NDM-1-And OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011;55(3):1274-8. Authors document that NDM-1 producing isolates were disseminated in Indian health care facilities as early as 2006.
12. Centers for Disease Control and Prevention (CDC). Detection of Enterobacteriaceae isolates carrying metallo-β-lactamase -United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59 (24):750.
13. Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66(6):1255-9.
14. Chihara S, Okuzumi K, Yamamoto Y, et al. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan. Clin Infect Dis. 2011;52(1):153-4.
15. Chu Y-W, Tung VMN, Cheung TKM, et al. Carbapenemases in enterobacteria, Hong Kong, China, 2000. Emerg Infect Dis. 2011;17(1):130-2.
16. D'Andrea MM, Venturelli C, Giani T, et al. Persistent carriage and infection by multi-drug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J Clin Microbiol. 2011;49(7):2755-8.
17. Deshpande P, Shetty A, Kapadia F, et al. New Delhi metallo 1: Have carbapenems met their doom? Clin Infect Dis. 2010;51 (10):1222.
18. Espinal P, Fugazza G, Lopez Y, et al. Dissemination of a NDM-2 producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemo. 2011;55:5396-8.
19. Gaibani P, Ambretti S, Berlingeri A, et al. Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011.
20. Eurosurveillance. 2011;24;16(47). http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId020027
21. Gecaj-Gashi A, Hasani A, Bruqi B, Milliqi-Osmani G. Balkan NDM-1: Escape or transplant? Lancet Infect Dis. 2011;11:586.
22. Ghazawi A, Sonnevend A, Bonnin RA, et al. NDM-2-carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect. 2011; doi: 10.1111/j.1469-0691.2011.03726.x. E-pub ahead of print
23. Göttig S, Pfeifer Y, Wichelhaus TA, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10(12):828-9.
24. Hammerum AM, Toleman MA, Hansen F, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10 (12):829-30.
25. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55 (12):5952-4.
26. Jamal W, Rotimi VO, Albert MJ, et al. Emergence of nosocomial New Delhi metallo-β-lactamase (NDM-1) producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Letter. International J Antimicrob Agents 2011; E-pub ahead of print
27. Jovic B, Lepsanovic Z, Suljagic V, et al. Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011;55(8):3929-31.
28. Kaase M, Nordmann P, Wichelhaus TA, et al. NDM-2-carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011;66:1260-2.
29. Koh TH, Khoo CT, Wijaya L, et al. Global spread of New Delhi metallo-β-lactamase-1. Lancet Infect Dis. 2010;10(12):828.
30. Lascols C, Hacket M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-B-lactamase in India: Data from the SMART study (2009). J Antimicrob Chemother. 2011;66:1992-7.
31. Leverstein-Van Hall MA, Stuart JC, Voets GM, et al. Global spread of New Delhi metallo-β-lactamase-1. Lancet Infect Dis. 2010;10 (12):830-1.
32. Mochon AB, Garner OB, Hindler JA, et al. New Delhi metallo-β- Lactamase (NDM-1)-producing Klebsiella pneumoniae: Case report and laboratory detection strategies. J Clin Microbiol. 2011;49 (4):1667-70.
33. Muir A, Weinbren JM. New Delhi metallo-β-lactamase: A cautionary tale. J Hospital Infect. 2010;75:239-40.
34. Mulvey MR, Grant JM, Plewes K, et al. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis. 2011;17(1):103-6.
35. Nordmann P, Couard J-P, Sansot D, Poirel L. Emergence of an autochthonous and community-Acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clin Infect Dis. 2012;54(1):150-1.
36. Peirano G, Ahmed-Bentley J, Woodford N, Pitout JD. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis. 2011;17(2):242-4.
37. Peirano G, Pillai DR, Pitondo-Silva A, et al. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diag Microbiol Infect Dis. 2011;71:106-9.
38. Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother. 2011;66(10):2288-94.
39. Pfeifer Y, Witte W, Holfelder M, et al. NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother. 2011;55 (3):1318-9.
40. Poirel L, Al Maskari Z, Al Rashdi F, et al. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother. 2011;66(2):304-6.
41. Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother. 2011;66(12):2781-3.
42. Poirel L, Fortineau N, Nordmann P. International Transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother. 2011;55(4):1821-2.
43. Poirel L, Hombrouck-Alet C, Freneaux C, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10 (12):832.
44. Poirel L, Lagrutta E, Taylor P, et al. Emergence of metallo-β- lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010;54(11):4914-6.
45. Poirel L, Lascols C, Bernabeu S, Nordmann P. NDM-1-producing Klebsiella pneumoniae in Mauritius. Antimicrob Agents Chemother. 2012;56(1):598-9.
46. Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother. 2011;55(2):934-6.
47. Poirel L, Ros A, Carricajo A, et al. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother. 2011;55(1):447-8.
48. Poirel L, Schrenzel J, Cherkaoui A, et al.: Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother. 2011;66(8):1730-3.
49. Potron A, Poirel L, Verdavaine D, Nordmann P. Importation of KPCproducing Escherichia coli from India. J Antimicrob Chemother 2012;doi: Jac/jac/dkr426. 3 Oct 2011. E-pub ahead of print
50. Roy S, Singh AK, Viswanathan R, et al. Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. J Antimicrob Chemother. 2011;66:2773-80.
51. Samuelsen O, Thilesen CM, Heggelund L, et al. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother. 2011;66(3):670-2.
52. Savard P, Gopinath R, Zhu W, et al. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother. 2011;55(12):5957-8.
53. Sidjabat H, Nimmo GR,Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis. 2011;52(4):481-4.
54. Sole M, Pitart C, Roca I, et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother. 2011;55(9):4402-4.
55. Tijet N, Alexander DC, Richardson D, et al. New Delhi metallobeta-lactamase, Ontario, Canada. Emerg Infect Dis. 2011;17 (2):306-7.
56. Wu HS, Chen TL, Chen IC, et al. First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. J Chin Med Assoc. 2010;73(11):596-8.
57. Zarfel G, Hoenigl M, Leitner E, et al. Emergence of New Delhi metallo-β-lactamase, Austria. Emerg Infect Dis. 2011;17(1):129-30.
58. Struelens MJ, Monnet DL, Magiorakos AP, et al. European NDM-1 Survey Participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: Emergence and response in Europe. Euro Surveill. 2010;15(46). Available online at www.eurosurveillance.org Authors provide excellent summary of cases in Europe. Survey shows that guidelines are not available in many countries for detection and management of patients with NDM-1-producing bacteria.
59. ProMED. Gram negative bacilli, multidrug resistant -South Africa: NDM-1, nosocomial. Posted 18 Oct 2011.
60. Roy S, Viswanathan R, Singh AK, et al. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India. J Antimicrob Chemo. 2011;66(6):1411-3.
61. Livermore DM, Walsh TR, Toleman M, Woodford N. Balkan NDM-1: Escape or transplant? Lancet Infect Dis. 2011;11:164.
62. Ivanovski N, Masin J, Rambabova-Busljetic I, et al. The outcome of commercial kidney transplant tourism in Pakistan. Clin Transplant. 2011;25:171-3.
63. Poirel L, Hervé V, Hombrouck-Alet C, Nordmann P. Long-Term carriage of NDM-1-producing Escherichia coli. J Antimicrob Chemother. 2011;66(9):2185-6.
64. Castanheira M, Mendes RE, Woosley LN, Jones RN. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. From Europe and the Americas: report from the SENTRY antimicrobial surveillance programs (2007-09). Letter. J Antimicrob Chemother 2011. doi:10.1093/jac/dkr081. Advance access publication 18 March 2011. Broad survey of isolates from multiple countries documents early presence in India and absence in other countries.
65. Huang T-D, Bogaerts P, Berhin C, et al. Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium. Euro Surveill. 2011;16(26): Available online at www.eurosurveillance.org
66. Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, the SMART India Working Group. Antibiotic susceptibility of intra-Abdominal infection isolates from Indian hospital during 2008. J Med Microbiol. 2010;59:1050-4.
67. Deshpande R, Rodrigues C, Shetty A, et al. New Delhi metallo-β- lactamase (NDM-1) in Enterobacteriaceae: Treatment options with carbapenems compromised. J Assoc Physicians India. 2010;58:147-9. Authors document that NDM-1-producing bacteria are common in some Indian hospitals.
68. Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broadspectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gramnegative bacteria? J Antimicrob Chemother. 2011;66(4):689-92.
69. Seema K, Sen MR, Upadhyay S, Bhattacharjee A. Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in northern India. J Antimicrob Chemother. 2011;66(7):1646-7.
70. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: An environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355-62. Authors document that NDM-1-producing bacteria can be found in water samples, including tap water, from central New Delhi and are present in many bacterial species, including Vibrio cholerae. They show that transfer of resistance is most efficient at 30; C.
71. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 2011;19(12):588-95. Authors provide a current review.
72. Carattoli A, Villa L, Poirel L, et al. Evolution of IncA/C bla cmy-2 carrying plasmids by acquisition of the blaNDM-1 carbapenemase gene. Antimicrob Agents Chemother E-pub ahead of print 28 Nov 2011
73. Moellering Jr. RC. NDM-1-A cause for worldwide concern. N Engl J Med. 2010;363(25):2377-9.
74. Livermore DM, Warner M, Mushtaq S, et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37(5):415-9.
75. Bonomo RA. New Delhi metallo-B-lactamase and multidrug resistance: A global SOS? Clin Infect Dis. 2011;52:485-7. Author describes the dire situation with increasing multi-drug resistance.
76. Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011;55(11):5403-7.
77. Mushtaq S, Irfan S, Sarma JB, et al. Phylogenetic diversity of Escherichia coli strains producing NDM-Type carbapenemases. J Antimicrob Chemother. 2011;66:2002-5.
78. Pfeifer Y, Wilharm G, Zander E, et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998-2001.
79. Potron A, Poirel L, Nordmann P. Plasmid-mediated transfer of the blaNDM-1 gene in Gram-negative rods. FEMS Microbiol Lett. 2011;324(2):111-6. Investigators study plasmid-mediated transfer of NDM-1 under different conditions and between different types of bacteria.
80. Fuursted K, Scholer L, Hansen F, et al.: Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-β-lactamase-1 (NDM-1). Microbes Infection 2011; E-pub ahead of print.
81. Peirano G, Schreckenberger PC, Pitout JD. Characteristics of NDM-1-producing Escherichia coli that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother. 2011;55 (6):2986-8.
82. Ho PL, Lo WU, Yeung MK, et al. Complete sequencing of a pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS ONE. 2011;6(3):e17989. Investigators find sequences from many different organisms in the plasmid carrying NDM-1.
83. Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-Throughput genome sequencing. Antimicrob Agents Chemother. 2011;55(9):4224-9.
84. Kumarasamy K, Kalyanasundaram A. Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. J Antimicrob Chemother 2012. doi:10.1093/jac/dkr431. E-pub ahead of print 11 Oct 2011
85. Naas T, Ergani A, Carrer A, Nordmann P. Real-Time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother. 2011;55(9):4038-43.
86. Nordmann P, Poirel L, Carrër A, et al. How to detect NDM-1 producers. J Clin Microbiol. 2011;49(2):718-21.
87. Stokes HW, Gillings MR. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol Rev. 2011;35:790-819.
88. Walsh TR, Toleman MA. The emergence of a pan-resistant Gramnegative pathogens merits a rapid global political response. J Antimicrob Chemother 2012;67:1-3. Authors call for global response to multi-drug resistance.
89. Goel N, Wattal C, Oberoi JK, et al. Trend analysis of antimicrobial consumption and development of resistance in nonfermenters in a tertiary care hospital in Delhi, India. J Antimicrob Chemother 2011;66:1625-30. Authors provide data for one hospital in Delhi and document increasing use of broad spectrum antibiotics.
90. Ghafur AK. An obituary -on the death of antibiotics? J Assoc Physicians India. 2010;58:143-4.
91. Choffnes ER, Relman DA, Mack A. Rapporteurs. Antibiotic resistance: Implications for global health and novel intervention strategies. Workshop summary. Forum on Microbial Threats: Institute of Medicine. Washington: The National Academies Press; 2010. p. 496.
92. UN News Centre. Mobile telephones more common that toilets in India, UN report finds. 2010. http://www.un.org/apps/news/story. asp?NewsID034369
93. O'Brien TF, PilarPla MD, Mayer KH, et al. Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science. 1985;230:87-8. (Pubitemid 16221624)
94. Murray BE, Mathewson JJ, DuPont HL, et al. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother. 1990;34 (4):515-8. (Pubitemid 20122274)
95. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-Type extended-spectrum β-lactamases: A prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564-8. This study documents that travelers frequently pick up resistant bacteria during international travel; about a quarter carry them for extended periods (at least 6 months).
96. Peirano G, Laupland KB, Gregson DB, Pitout JDD. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med. 2011;18:299-303.
97. UNWTO Tourism Highlights, 2011 Edition. Available from: Http://mkt.unwto.org/sites/all/files/docpdf/unwtohighlights11enlr-1.pdf.
98. Milstein A, Smith M. America's new refugees-seeking affordable health care offshore. N Engl J Med. 2006;355:1637-40. (Pubitemid 44583952)
99. Rogers BA, Aminzadeh Z, Hayashhi Y, Paterson DL. Country-Tocountry transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53:49-56.
100. Shetty P. Medical tourism booms in India, but at what cost? Lancet. 2010;376:671-2.